Results 181 to 190 of about 54,490 (219)
Some of the next articles are maybe not open access.
Cryptococcus neoformans, Cryptococcus gattii: Serotypes in Venezuela
Mycopathologia, 2008Cryptococcus neoformans is one of the medically important yeast-like fungi. C. neoformans var. gatti has been made a species: C. gatti. In our country, there are few studies about these two species and their serotypes. The aim of this study was to determine the distribution of C. neoformans and C.
C, Pérez +6 more
openaire +2 more sources
Cryptococcus neoformans variety gattii
Medical Mycology, 2001Cryptococcus neoformans var. gattii is emerging as a primary human pathogen which is distinct genetically and biochemically from C. neoformans var. neoformans. There is increasing evidence that it should be reclassified as a separate species within the Tremellales. In nature, C. n. var.
openaire +2 more sources
Drug resistance in Cryptococcus neoformans
Drug Resistance Updates, 1999Cryptococcus neoformans has become a major opportunistic fungal pathogen worldwide. Successful treatment of invasive disease with this fungus has used amphotericin B, flucytosine and various azoles. However, treatment failures continue to occur for a variety of reasons including direct antifungal drug resistance.
John R., Perfect, Gary M., Cox
openaire +2 more sources
Phospholipase activity in Cryptococcus neoformans
Mycopathologia, 1996Phospholipases have only been detected in a few fungi and yeasts, in particular in Candida albicans. Secreted phospholipases are considered by some researchers to be a potential factor of virulence and pathogenicity in C. albicans. Twenty-three Cryptococcus neoformans strains were tested in order to observe phospholipase production.
V, Vidotto +5 more
openaire +2 more sources
Canadian journal of medical technology, 1998
Arturo Casadevall, John R. Perfect
openaire +3 more sources
Arturo Casadevall, John R. Perfect
openaire +3 more sources